Total Liabilities: The total value of all possible claims against the corporation.
Forte Biosciences, Inc. (FBRX) had Total Liabilities of $25.12M for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
-- |
|
$-22.14M |
|
-- |
|
-- |
|
$22.44M |
|
$-22.44M |
|
$0.68M |
|
$-21.76M |
|
$-21.76M |
|
$-22.14M |
|
$-22.14M |
|
$-22.14M |
|
$-22.14M |
|
$-22.44M |
|
$-22.42M |
|
17.84M |
|
17.84M |
|
$-1.24 |
|
$-1.24 |
|
| Balance Sheet Financials | |
$65.11M |
|
$0.11M |
|
$2.11M |
|
$67.22M |
|
$23.65M |
|
-- |
|
$1.48M |
|
|
Total Liabilities |
$25.12M |
$42.10M |
|
$42.10M |
|
$42.10M |
|
13.91M |
|
| Cash Flow Statement Financials | |
$-18.81M |
|
-- |
|
$0.07M |
|
$76.96M |
|
$58.22M |
|
$-18.73M |
|
$3.18M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.75 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-18.81M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-52.58% |
|
-52.58% |
|
-32.93% |
|
-52.58% |
|
$3.03 |
|
$-1.05 |
|
$-1.05 |
|